Reports
-
La mejor inyección para los países en vías de desarrollo. Panorama del acceso y la I+D de vacunas
Last updated 10 May 2010
www.msfaccess.org/our-work/addressing-medical-challenges/article/1325 -
Améliorer la prise en charge du paludisme sévère chez l’enfant- Soutenir les gouvernements africains en vue d’une modification rapide des protocoles
Le paludisme continue d’être la première cause de mortalité d’enfants en Afrique. Sur les 781 000 décès recensés en 2009, 91% des victimes vivaient sur le continent africain et 85% étaient...
Last updated 19 April 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/1323 -
An Evaluation of Drug-Resistant TB Scale-Up
Last updated 6 July 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/885 -
Making the Switch: Ensuring access to improved treatment for severe malaria in Africa
Malaria continues to be the leading cause of death in African children. Of an estimated 781,000 malaria-related deaths reported in 2009, 91% occurred on the African continent, and 85% were among children...
Last updated 19 April 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/887 -
Scaling-up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha
Last updated 22 March 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/889 -
DR-TB Drugs Under the Microscope
MSF's new report outlines the issues surrounding access to DR-TB drugs, including - the limited number of quality sources, including few quality assured producers and limited sources of the active pharmaceutical...
Last updated 22 March 2011
www.msfaccess.org/our-work/addressing-medical-challenges/article/888 -
Untangling the Web of Antiretroviral Price Reductions: 13th edition, July 2010
The Access Campaign first published a report on AIDS drug prices in 2001, in response to the lack of transparent information available for treatment providers to be able to make informed purchasing decisions. ...
Last updated 9 July 2010
www.msfaccess.org/our-work/addressing-medical-challenges/article/894 -
No time to quit: HIV/AIDS treatment gap widening in Africa
EXECUTIVE SUMMARY At the end of the 90s, Médecins Sans Frontières (MSF) got involved in HIV/AIDS because we viewed it as an emergency: today, MSF still believes this is a crisis requiring an exceptional...
Last updated 27 May 2010
www.msfaccess.org/our-work/addressing-medical-challenges/article/895 -
Untangling the Web of Antiretroviral Price Reductions: 12th edition, January 2010
The Access Campaign first published a report on AIDS drug prices in 2001, in response to the lack of transparent information available for treatment providers to be able to make informed purchasing decisions. ...
Last updated 21 January 2010
www.msfaccess.org/our-work/addressing-medical-challenges/article/897 -
Giving developing countries the best shot: An overview of vaccine access and R&D
Vaccines have made possible some of the greatest public health successes in the past century.
Last updated 10 May 2010
www.msfaccess.org/our-work/addressing-medical-challenges/article/896
